Navi Therapeutics raises Series A to advance AI-driven next-generation ADC platform
China-based biotech Navi Therapeutics (Shanghai) Co., Ltd. (“Navi”) has completed a Series A financing round, marking the company’s second fundraising since its founding roughly 18 months ago and bringing its cumulative funding to…